Industry Update: Biotechnology

IBiotech industry updatendustry Highlights

  • On December 28, 2021, Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. for approximately $3.2 billion. Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-mediated diseases; and neurodegenerative diseases and pain.
  • On December 14, 2021, Global biotechnology leader CSL Limited and Vifor Pharma Ltd, a global specialty pharmaceutical company with leadership in Iron Deficiency, Nephrology & Cardio-Renal Therapies, announced that they have entered into a definitive agreement for CSL to launch an all-cash public tender offer to acquire allVifor Pharma shares for US$179.25 per share, or approximately $11.7 billion.

Past Industry Updates

Biotechnology: February 2022

Biotechnology: October 2021

Biotechnology: July 2021

Biotechnology: May 2021

Biotechnology: January 2021

Biotechnology: October 2020

Biotechnology: July 2020

Biotechnology: May 2020

Biotechnology: December 2019

Biotechnology: October 2019

More Industry Reports